专利检索 ap:("Sanofi-Synthélabo") AND inv:"BERNAT, André" 第 1 页

1.

发明公开
UTILISATION DES AGONISTES DES RECEPTEURS BETA-3 ADRENERGIQUES POUR LA PREPARATION DE MEDICAMENTS CICATRISANTS 失效
标题翻译： β-3肾上腺素能受体激动剂的用于伤口愈合的资金的生产使用

公开(公告)号：EP0966276A1

公开(公告)日：1999-12-29

申请号：EP98903099.0

申请日：1998-01-21

申请人： Sanofi-Synthélabo

发明人： BERNAT, André , HERBERT, Jean-Marc , ARNONE, Michèle

IPC分类号： A61P17 , A61K31

CPC分类号： A61K31/137 , A61K31/138

摘要： The invention concerns the use of agonists of adrenergic beta-3 receptors for preparing wound-healing medicines and pharmaceutical compositions for said use.

2.

发明公开
INHIBITEUR DU FACTEUR Xa SEUL OU EN COMBINAISON AVEC UN ANTIAGREGANT PLAQUETTAIRE, CONTRE LA THROMBOSE ARTERIELLE 失效
标题翻译：使用的因子的抑制性寡糖WITH A抗凝剂动脉血栓形成的治疗

公开(公告)号：EP0986376A1

公开(公告)日：2000-03-22

申请号：EP98929521.7

申请日：1998-06-09

申请人： Sanofi-Synthélabo , Akzo Nobel N.V.

发明人： BERNAT, André , HERBERT, Jean-Marc , PETITOU, Maurice , VAN AMSTERDAM, Ronald

IPC分类号： A61K31/00 , A61K31/70 , A61K31/40

CPC分类号： A61K31/7024 , A61K31/00 , A61K31/40 , A61K31/435 , A61K31/445 , A61K31/702 , A61K31/715 , A61K45/06 , A61K2300/00

摘要： The invention concerns the use of direct or indirect selective inhibitors of the Xa factor acting via antithrombin III, on their own or combined with one or several compounds with platelet antiaggregating activity, for preparing medicines for preventing or treating arterial thromboembolism. The invention also concerns pharmaceutical compositions containing one or several direct or indirect selective inhibitors of Xa factor acting via antithrombin III in association with one or several compounds with platelet antiaggregating activity, and, optionally one or several pharmaceutically acceptable carriers.